Study of Immediate Start of Progestin Contraceptives in Medical Abortion

Phase 4

Completed

• Conditions: Contraception

• Registration Number: NCT01902485
• Lead Sponsor: Gynuity Health Projects

Brief Summary

This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-07
• Study First Submitted: 2013-07-15
• Study First Submitted QC: 2013-07-15
• Study First Posted: 2013-07-18
• Primary Completion: 2015-12
• Study Completion: 2015-12
• Status Verified: 2016-03
• Last Update Submitted: 2016-03-03
• Last Update Posted: 2016-03-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 937

Inclusion Criteria

Women having medical abortion desiring progestin-based contraceptives (injectables or implants)

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Repeat Pregnancy	6 months after enrollment
Medical Abortion Failure	One month after enrollment

Trial Locations

Locations (8)

Planned Parenthood of the Pacific Southwest; 🇺🇸 Chula Vista, California, United States

Planned Parenthood Northern California; 🇺🇸 Eureka, California, United States

Planned Parenthood of Southern New England; 🇺🇸 Stamford, Connecticut, United States

Bayview Medical Center; 🇺🇸 Baltimore, Maryland, United States

Boston Medical Center; 🇺🇸 Boston, Massachusetts, United States

Planned Parenthood League of Massachusetts; 🇺🇸 Boston, Massachusetts, United States

Centro de Salud Beatriz Velasco de Aleman; 🇲🇽 Mexico City, Mexico

Centro de Salud Santa Catarina; 🇲🇽 Mexico City, Mexico